Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study for Optimization of 6% Hydroxyethyl Starch Based Indocyanine Green Near-infrared Fluorescence Navigated Sentinel Lymph Node Biopsy for Breast Cancer Patients

NCT05365204 is registered in ClinicalTrials.gov with National Taiwan University Hospital Hsin-Chu Branch as lead sponsor.

NCT NCT05365204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05365204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study for Optimization of 6% Hydroxyethyl Starch Based Indocyanine Green Near-infrared Fluorescence Navigated Sentinel Lymph Node Biopsy for Breast Cancer Patients
Lead sponsor
National Taiwan University Hospital Hsin-Chu Branch
Phase
Phase 1
Overall status
Unknown status
Start date
April 8, 2022
Completion date
April 7, 2023
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, sentinel lymph node